Thomas P Conrads
Inventor
Stats
- 5 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 9 US Applications Filed
- 58 Total Citation Count
- Jan 12, 2018 Most Recent Filing
- Feb 16, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 1
1 | 2003
2007 |
EXPRESSION PATHOLOGY, INC. | 2
| 2013
|
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2
2 2 | 2011
2013 2016 |
THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 1
| 2007
|
University of Pittsburgh - Of the Commonwealth Sys tem of Higher Education | 1
| 2016
|
BATTELLE MEMORIAL INSTITUTE | 2
| 2001
|
Inventor Addresses
Address | Duration |
---|---|
Frederick, MD, US | Jun 09, 09 - Jun 09, 09 |
Pittsburgh, PA, US | Jun 11, 09 - Jun 11, 09 |
Reston, VA, US | Jan 12, 12 - Aug 16, 18 |
Richland, WA | Nov 16, 04 - Nov 16, 04 |
Richland, WA, US | Aug 29, 02 - Aug 29, 02 |
Rockville, MD, US | Jan 01, 15 - Jan 01, 15 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2018/0230,205 | 2018 | ANTIBODIES TO ENDOPLASMIN AND THEIR USE | 0 |
9902766 | 2018 | Antibodies to endoplasmin and their use | 0 |
2016/0207,990 | 2016 | ANTIBODIES TO ENDOPLASMIN AND THEIR USE | 0 |
9340608 | 2016 | Antibodies to endoplasmin and their use | 0 |
2015/0005,183 | 2015 | PROTEIN BIOMARKERS OF LATE STAGE BREAST CANCER | 3 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.